Epidermal Growth Factor Receptor (EGFR)‐Tyrosine Kinase Inhibitor Treatment and Salvage Chemotherapy in EGFR‐Mutated Elderly Pulmonary Adenocarcinoma Patients

The Oncologist ◽

10.1634/theoncologist.2014-0352 ◽

2015 ◽

Vol 20 (7) ◽

pp. 758-766 ◽

Author(s):

Yen‐Han Tseng ◽

Yen‐Chiang Tseng ◽

Yi‐hsuan Lin ◽

Yu‐Chin Lee ◽

Reury‐Perng Perng ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Salvage Chemotherapy ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Egfr Mutated ◽

Inhibitor Treatment

Download Full-text

The influence of intracellular epidermal growth factor receptor (EGFR) signal activation on the outcome of EGFR tyrosine kinase inhibitor treatment for pulmonary adenocarcinoma

Surgery Today ◽

10.1007/s00595-011-4514-2 ◽

2011 ◽

Vol 41 (6) ◽

pp. 818-823 ◽

Author(s):

Daigo Kawano ◽

Tokujiro Yano ◽

Fumihiro Shoji ◽

Kensaku Ito ◽

Yosuke Morodomi ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Signal Activation ◽

Inhibitor Treatment

Download Full-text

Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI)

Journal of Chemotherapy ◽

10.1179/1973947815y.0000000027 ◽

2016 ◽

Vol 28 (1) ◽

pp. 50-58 ◽

Author(s):

Yen-Han Tseng ◽

Hsiu-Ying Hung ◽

Yi-Chen Sung ◽

Yen-Chiang Tseng ◽

Yu-Chin Lee ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Download Full-text

Quantification of epidermal growth factor receptor ( EGFR ) mutation may be a predictor of EGFR ‐tyrosine kinase inhibitor treatment response

Thoracic Cancer ◽

10.1111/1759-7714.12378 ◽

2016 ◽

Vol 7 (6) ◽

pp. 639-647 ◽

Author(s):

Ha Young Park ◽

Hyung Joo Oh ◽

Ki‐Hyun Kim ◽

Tae‐Ok Kim ◽

Cheol‐Kyu Park ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Egfr Mutation ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

First‐line epidermal growth factor receptor ( EGFR )–tyrosine kinase inhibitor alone or with whole‐brain radiotherapy for brain metastases in patients with EGFR ‐mutated lung adenocarcinoma

Cancer Science ◽

10.1111/cas.13079 ◽

2016 ◽

Vol 107 (12) ◽

pp. 1800-1805 ◽

Author(s):

Yongshun Chen ◽

Jing Yang ◽

Xue Li ◽

Daxuan Hao ◽

Xiaoyuan Wu ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Whole Brain Radiotherapy ◽

Egfr Tyrosine Kinase Inhibitor ◽

Brain Radiotherapy ◽

Epidermal Growth ◽

Download Full-text

Cytoplasmic YAP Expression is Associated with Prolonged Survival in Patients with Lung Adenocarcinomas and Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment

Annals of Surgical Oncology ◽

10.1245/s10434-014-3715-5 ◽

2014 ◽

Vol 21 (S4) ◽

pp. 610-618 ◽

Author(s):

Ping-Li Sun ◽

Ji Eun Kim ◽

Seol Bong Yoo ◽

Hyojin Kim ◽

Yan Jin ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Lung Adenocarcinomas ◽

Inhibitor Treatment

Download Full-text

KRASstatus and resistance to epidermal growth factor receptor tyrosine-kinase inhibitor treatment in patients with metastatic colorectal cancer: a meta-analysis

Colorectal Disease ◽

10.1111/codi.12749 ◽

2014 ◽

Vol 16 (11) ◽

pp. O370-O378 ◽

Author(s):

W. Li ◽

Q. Shi ◽

W. Wang ◽

J. Liu ◽

J. Ren ◽

...

Keyword(s):

Colorectal Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Meta Analysis ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Inhibitor Treatment

Download Full-text

Thoracic surgery improved overall survival in patients with stage IIIB–IV epidermal growth factor receptor-mutant lung adenocarcinoma who received and responded to tyrosine kinase inhibitor treatment

Lung Cancer ◽

10.1016/j.lungcan.2021.10.003 ◽

2021 ◽

Author(s):

Yu-Ning Chien ◽

Yi-Chun Lin ◽

Chia-Lun Chang ◽

Wei-Chun Lin ◽

Szu-Yuan Wu

Keyword(s):

Overall Survival ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Thoracic Surgery ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Receptor Mutant ◽

Inhibitor Treatment

Download Full-text

Abstract C161: Modulation of thymidine phosphorylase (TP) expression in breast cancer cell lines exposed to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor ZD1839

10.1158/1535-7163.targ-09-c161 ◽

2009 ◽

Author(s):

Maria Ait‐Tihyaty ◽

Zakaria Rachid ◽

Bertrand J. Jean‐Claude

Keyword(s):

Breast Cancer ◽

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Thymidine Phosphorylase ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Breast Cancer Cell Lines ◽

Egfr Tyrosine Kinase Inhibitor ◽

Epidermal Growth

Download Full-text

Abstract CT032: TATTON Phase Ib expansion cohort: Osimertinib plus savolitinib for patients (pts) withEGFR-mutant,MET-amplified NSCLC after progression on prior first/second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)

10.1158/1538-7445.am2019-ct032 ◽

2019 ◽

Author(s):

Helena Yu ◽

Myung-Ju Ahn ◽

Sang-We Kim ◽

Byoung Chul Cho ◽

Lecia Sequist ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Phase Ib ◽

Epidermal Growth ◽

Expansion Cohort

Download Full-text

Abstract CT032: TATTON Phase Ib expansion cohort: Osimertinib plus savolitinib for patients (pts) withEGFR-mutant,MET-amplified NSCLC after progression on prior first/second-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)

10.1158/1538-7445.sabcs18-ct032 ◽

2019 ◽

Author(s):

Helena Yu ◽

Myung-Ju Ahn ◽

Sang-We Kim ◽

Byoung Chul Cho ◽

Lecia Sequist ◽

...

Keyword(s):

Epidermal Growth Factor Receptor ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Phase Ib ◽

Epidermal Growth ◽

Expansion Cohort

Download Full-text